Style | Citing Format |
---|---|
MLA | Damavandi AR, et al.. "Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease." Applied Nanoscience (Switzerland), vol. 13, no. 6, 2023, pp. 4043-4073. |
APA | Damavandi AR, Mirmosayyeb O, Ebrahimi N, Zalpoor H, Khalilian P, Yahiazadeh S, Eskandari N, Rahdar A, Kumar PS, Pandey S (2023). Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease. Applied Nanoscience (Switzerland), 13(6), 4043-4073. |
Chicago | Damavandi AR, Mirmosayyeb O, Ebrahimi N, Zalpoor H, Khalilian P, Yahiazadeh S, Eskandari N, Rahdar A, Kumar PS, Pandey S. "Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease." Applied Nanoscience (Switzerland) 13, no. 6 (2023): 4043-4073. |
Harvard | Damavandi AR et al. (2023) 'Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease', Applied Nanoscience (Switzerland), 13(6), pp. 4043-4073. |
Vancouver | Damavandi AR, Mirmosayyeb O, Ebrahimi N, Zalpoor H, Khalilian P, Yahiazadeh S, et al.. Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease. Applied Nanoscience (Switzerland). 2023;13(6):4043-4073. |
BibTex | @article{ author = {Damavandi AR and Mirmosayyeb O and Ebrahimi N and Zalpoor H and Khalilian P and Yahiazadeh S and Eskandari N and Rahdar A and Kumar PS and Pandey S}, title = {Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease}, journal = {Applied Nanoscience (Switzerland)}, volume = {13}, number = {6}, pages = {4043-4073}, year = {2023} } |
RIS | TY - JOUR AU - Damavandi AR AU - Mirmosayyeb O AU - Ebrahimi N AU - Zalpoor H AU - Khalilian P AU - Yahiazadeh S AU - Eskandari N AU - Rahdar A AU - Kumar PS AU - Pandey S TI - Advances in Nanotechnology Versus Stem Cell Therapy for the Theranostics of Multiple Sclerosis Disease JO - Applied Nanoscience (Switzerland) VL - 13 IS - 6 SP - 4043 EP - 4073 PY - 2023 ER - |